Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.

Hirst C, Ingram G, Swingler R, Compston DA, Pickersgill T, Robertson NP.

J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1137-43. doi: 10.1136/jnnp.2007.133785. Epub 2008 Feb 26.

PMID:
18303106
2.

Change in MS-related disability in a population-based cohort: a 10-year follow-up study.

Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Weinshenker BG, Rodriguez M.

Neurology. 2004 Jan 13;62(1):51-9.

PMID:
14718697
3.

Longitudinal follow-up of "benign" multiple sclerosis at 20 years.

Sayao AL, Devonshire V, Tremlett H.

Neurology. 2007 Feb 13;68(7):496-500.

PMID:
17296915
4.

Disability profile of MS did not change over 10 years in a population-based prevalence cohort.

Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M.

Neurology. 2004 Feb 24;62(4):601-6. Review.

PMID:
14981177
5.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
6.
7.

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.

Sartori A, Abdoli M, Freedman MS.

J Neurol. 2017 Jun;264(6):1068-1075. doi: 10.1007/s00415-017-8487-y. Epub 2017 Apr 17.

PMID:
28417192
8.

Benign multiple sclerosis: a need for a consensus.

Glad SB, Aarseth JH, Nyland H, Riise T, Myhr KM.

Acta Neurol Scand Suppl. 2010;(190):44-50. doi: 10.1111/j.1600-0404.2010.01375.x.

PMID:
20586735
9.

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.

Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, Thompson AJ, Miller DH.

Brain. 2008 Mar;131(Pt 3):808-17. doi: 10.1093/brain/awm329. Epub 2008 Jan 29.

PMID:
18234696
10.

One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.

Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, Polman CH.

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42. Erratum in: J Neurol Neurosurg Psychiatry. 2003 May;74(5):694.

11.

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

Rudick RA, Lee JC, Nakamura K, Fisher E.

J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19.

12.

Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.

Huda S, Cavey A, Izat A, Mattison P, Boggild M, Palace J.

J Neurol Sci. 2016 Mar 15;362:66-8. doi: 10.1016/j.jns.2016.01.011. Epub 2016 Jan 6.

PMID:
26944120
13.

Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.

Ravnborg M, Blinkenberg M, Sellebjerg F, Ballegaard M, Larsen SH, Sørensen PS.

Mult Scler. 2005 Feb;11(1):81-4.

PMID:
15732271
14.

Patient reported outcomes in benign multiple sclerosis.

Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI.

Mult Scler. 2011 Jul;17(7):876-84. doi: 10.1177/1352458511398370. Epub 2011 Mar 3.

PMID:
21372114
15.

Mitoxantrone in worsening secondary progressive multiple sclerosis: A prospective, open-label study.

Khatri BO, Wroblewski M, Kramer J, Dukic M, Poplar A, Anderson AJ.

Curr Ther Res Clin Exp. 2006 Jan;67(1):55-65. doi: 10.1016/j.curtheres.2006.02.004.

16.
17.

Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.

Rabadi MH, Vincent AS.

Disabil Rehabil. 2013;35(22):1877-84. doi: 10.3109/09638288.2013.766269. Epub 2013 Apr 19.

PMID:
23600712
18.

The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.

McGuigan C, Hutchinson M.

J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):266-9.

19.

Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.

Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM.

Neurology. 2008 Mar 25;70(13 Pt 2):1084-91. doi: 10.1212/01.wnl.0000288179.86056.e1. Epub 2008 Jan 9.

PMID:
18184917
20.

Costs and quality of life in multiple sclerosis in The Netherlands.

Kobelt G, Berg J, Lindgren P, Anten B, Ekman M, Jongen PJ, Polman C, Uitdehaag B.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S55-64. Erratum in: Eur J Health Econ. 2007 Dec;8(4):359. Anten, Bert [added]; Ekman, Mattias [added]; Jongen, Peter J H [added]; Polman, Chris [added]; Uitdehaag, Bernard [added].

PMID:
17310343

Supplemental Content

Support Center